STOCK TITAN

Tecogen Reports First Quarter 2025 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Tecogen (NYSE American: TGEN) reported its Q1 2025 financial results, showing improved performance across key metrics. The company achieved revenues of $7.28 million, up 17.6% from $6.19 million in Q1 2024. The net loss decreased to $0.66 million ($0.03/share) from $1.10 million ($0.04/share) in the previous year. Gross margin improved to 44.3% from 41.6%. Products revenue saw significant growth of 69.9% to $2.53 million, while Services revenue increased 5.7% to $4.25 million. Energy Production revenue declined 26.7% to $0.50 million. The company's adjusted EBITDA loss narrowed to $0.38 million from $0.90 million. Operating expenses increased 5.2% to $3.82 million due to increased payroll, benefits, and recruitment costs. The company recently uplisted to NYSE American to enhance stock liquidity and visibility.
Tecogen (NYSE American: TGEN) ha comunicato i risultati finanziari del primo trimestre 2025, evidenziando un miglioramento delle performance nei principali indicatori. L'azienda ha registrato ricavi per 7,28 milioni di dollari, in crescita del 17,6% rispetto ai 6,19 milioni del primo trimestre 2024. La perdita netta si è ridotta a 0,66 milioni di dollari (0,03 dollari per azione) rispetto a 1,10 milioni (0,04 dollari per azione) dell'anno precedente. Il margine lordo è salito al 44,3% dal 41,6%. I ricavi da prodotti hanno registrato una crescita significativa del 69,9%, raggiungendo 2,53 milioni di dollari, mentre i ricavi da servizi sono aumentati del 5,7% a 4,25 milioni di dollari. I ricavi da produzione energetica sono invece diminuiti del 26,7%, attestandosi a 0,50 milioni di dollari. La perdita dell'EBITDA rettificato si è ridotta a 0,38 milioni da 0,90 milioni. Le spese operative sono aumentate del 5,2%, arrivando a 3,82 milioni di dollari, a causa dell'incremento dei costi per salari, benefici e reclutamento. Recentemente, l'azienda è stata quotata alla NYSE American per migliorare la liquidità e la visibilità delle azioni.
Tecogen (NYSE American: TGEN) informó sus resultados financieros del primer trimestre de 2025, mostrando una mejora en los principales indicadores. La compañía alcanzó ingresos de 7,28 millones de dólares, un aumento del 17,6% respecto a los 6,19 millones del primer trimestre de 2024. La pérdida neta disminuyó a 0,66 millones de dólares (0,03 dólares por acción) desde 1,10 millones (0,04 dólares por acción) del año anterior. El margen bruto mejoró al 44,3% desde el 41,6%. Los ingresos por productos crecieron significativamente un 69,9%, llegando a 2,53 millones de dólares, mientras que los ingresos por servicios aumentaron un 5,7% hasta 4,25 millones de dólares. Los ingresos por producción de energía disminuyeron un 26,7%, situándose en 0,50 millones de dólares. La pérdida del EBITDA ajustado se redujo a 0,38 millones desde 0,90 millones. Los gastos operativos aumentaron un 5,2% hasta 3,82 millones de dólares debido al incremento en salarios, beneficios y costos de reclutamiento. Recientemente, la compañía se listó en NYSE American para mejorar la liquidez y visibilidad de sus acciones.
Tecogen(NYSE American: TGEN)는 2025년 1분기 재무 실적을 발표하며 주요 지표 전반에서 성과가 개선되었음을 보였습니다. 회사는 매출 728만 달러를 기록했으며, 이는 2024년 1분기 619만 달러 대비 17.6% 증가한 수치입니다. 순손실은 66만 달러(주당 0.03달러)로 감소했으며, 전년 동기 110만 달러(주당 0.04달러)에서 줄어들었습니다. 총이익률은 41.6%에서 44.3%로 개선되었습니다. 제품 매출은 69.9% 크게 성장하여 253만 달러를 기록했고, 서비스 매출은 5.7% 증가하여 425만 달러에 달했습니다. 에너지 생산 매출은 26.7% 감소하여 50만 달러를 기록했습니다. 조정 EBITDA 손실은 90만 달러에서 38만 달러로 축소되었습니다. 급여, 복리후생, 채용 비용 증가로 인해 영업비용은 5.2% 증가한 382만 달러를 기록했습니다. 회사는 최근 NYSE American에 상장하여 주식 유동성과 가시성을 높였습니다.
Tecogen (NYSE American : TGEN) a publié ses résultats financiers du premier trimestre 2025, montrant une amélioration des performances sur les principaux indicateurs. La société a réalisé un chiffre d'affaires de 7,28 millions de dollars, en hausse de 17,6 % par rapport à 6,19 millions au T1 2024. La perte nette a diminué à 0,66 million de dollars (0,03 $/action) contre 1,10 million (0,04 $/action) l'année précédente. La marge brute s'est améliorée à 44,3 % contre 41,6 %. Les revenus produits ont connu une forte croissance de 69,9 %, atteignant 2,53 millions de dollars, tandis que les revenus des services ont augmenté de 5,7 % pour atteindre 4,25 millions. Les revenus de production d'énergie ont diminué de 26,7 % à 0,50 million. La perte d'EBITDA ajusté s'est réduite à 0,38 million contre 0,90 million. Les charges d'exploitation ont augmenté de 5,2 % à 3,82 millions en raison de la hausse des coûts de paie, avantages sociaux et recrutement. La société a récemment été introduite sur le NYSE American afin d'améliorer la liquidité et la visibilité de ses actions.
Tecogen (NYSE American: TGEN) veröffentlichte seine Finanzergebnisse für das erste Quartal 2025 und zeigte eine verbesserte Leistung bei den wichtigsten Kennzahlen. Das Unternehmen erzielte Umsätze von 7,28 Millionen US-Dollar, was einem Anstieg von 17,6 % gegenüber 6,19 Millionen US-Dollar im ersten Quartal 2024 entspricht. Der Nettoverlust verringerte sich auf 0,66 Millionen US-Dollar (0,03 US-Dollar pro Aktie) von 1,10 Millionen US-Dollar (0,04 US-Dollar pro Aktie) im Vorjahr. Die Bruttomarge verbesserte sich von 41,6 % auf 44,3 %. Die Produktumsätze wuchsen deutlich um 69,9 % auf 2,53 Millionen US-Dollar, während die Serviceerlöse um 5,7 % auf 4,25 Millionen US-Dollar stiegen. Die Erlöse aus der Energieproduktion sanken um 26,7 % auf 0,50 Millionen US-Dollar. Der bereinigte EBITDA-Verlust verringerte sich von 0,90 Millionen auf 0,38 Millionen US-Dollar. Die Betriebskosten stiegen um 5,2 % auf 3,82 Millionen US-Dollar aufgrund gestiegener Lohn-, Sozialleistungs- und Rekrutierungskosten. Das Unternehmen wurde kürzlich an der NYSE American gelistet, um die Liquidität und Sichtbarkeit der Aktie zu erhöhen.
Positive
  • Revenue increased 17.6% year-over-year to $7.28 million
  • Net loss decreased by $0.45 million to $0.66 million
  • Products revenue grew significantly by 69.9% to $2.53 million
  • Gross margin improved to 44.3% from 41.6%
  • Adjusted EBITDA loss narrowed from $0.90M to $0.38M
  • Successfully uplisted to NYSE American exchange
Negative
  • Company still operating at a net loss of $0.66 million
  • Operating expenses increased 5.2% to $3.82 million
  • Energy Production revenue declined 26.7% to $0.50 million
  • Negative adjusted EBITDA of $0.38 million

Insights

Tecogen showing financial improvement with 17.6% revenue growth and narrowed losses, though still operating at a deficit despite NYSE uplist.

Tecogen's Q1 2025 results demonstrate notable improvement across several financial metrics despite remaining in loss territory. The 17.6% revenue increase to $7.28 million was primarily driven by a substantial 69.9% surge in product sales, particularly in chillers and cogeneration equipment. This product segment growth signals potentially stronger market adoption of Tecogen's clean energy solutions.

While still operating at a loss, the company has successfully narrowed its quarterly deficit to $0.66 million from $1.10 million year-over-year, representing a 40% improvement. The gross margin expansion from 41.6% to 44.3% indicates enhanced operational efficiency in manufacturing and service delivery.

The improved Adjusted EBITDA, though still negative at $0.38 million (vs. $0.90 million loss in Q1 2024), shows Tecogen is moving toward operational sustainability. However, the 5.2% increase in operating expenses signals ongoing investments in growth initiatives, including R&D and strategic hiring.

The cash position of $4.07 million provides some runway but requires monitoring given the continued cash burn. The recent NYSE American uplist represents a strategic move to improve stock visibility and liquidity, potentially facilitating future capital raising if needed.

The segment performance reveals a strategic shift: strong product and service revenue growth offset by declining energy production revenue from expired contracts. This suggests a pivot toward equipment sales and maintenance rather than energy-as-a-service models. The company's mention of data center initiatives and the Vertiv partnership indicates efforts to target high-growth markets where reliable energy solutions are essential.

NORTH BILLERICA, MA / ACCESS Newswire / May 12, 2025 / Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean energy products, reported revenues of $7.28 million and net loss of $0.66 million for the quarter ended March 31, 2025 compared to revenues of $6.19 million, and a net loss of $1.10 million in 2024. Our cash and cash equivalents balance was $4.07 million at March 31, 2025.

Abinand Rangesh, CEO of Tecogen, reported that "there have been multiple exciting developments at Tecogen. We recently listed on the NYSE American stock exchange to increase liquidity and visibility of our stock. Across the board, our financial numbers also improved substantially. Our revenue for the quarter increased 17.6% and our adjusted EBITDA loss narrowed from $900k to $381k. Our gross profit margin also increased from 41.6% to 44.3%. Operating expenses were higher during the quarter due to increased R&D expenses, recruiter fees for strategic hires, and professional fees for the uplist. In addition to improving financials, we continue to make inroads on our data center strategy. During the conference call, I will update shareholders on interest from larger scale data center projects and the Vertiv partnership."

Key Takeaways

Net Loss and Earnings Per Share

  • Net loss for the quarter ended March 31, 2025 was $0.66 million compared to a net loss of $1.10 million for the same period of 2024, a decrease of $0.45 million, due to increased gross profit from our Products and Services segments. EPS for the quarter ended March 31, 2025 and 2024 was a loss of $0.03/share and $0.04/share, respectively.

Loss from Operations

  • Loss from operations for the quarter ended March 31, 2025 was $0.59 million compared to a loss from operations of $1.05 million for the same period in 2024, a decrease of $0.46 million, due to increased gross profit from our Products and Services segments.

Revenues

  • Revenues for the quarter ended March 31, 2025 were $7.28 million compared to $6.19 million for the same period in 2024, a 17.6% increase.

    • Products revenues in the quarter ended March 31, 2025 were $2.53 million compared to $1.49 million for the same period in 2024, an increase of 69.9%. The increase in revenue during the quarter ended March 31, 2025 is due to increased chiller and cogeneration revenue.

    • Services revenues in the quarter ended March 31, 2025 were $4.25 million, compared to $4.01 million for the same period in 2024, an increase of 5.7% due to increased revenues from existing contracts.

    • Energy Production revenues in the quarter ended March 31, 2025 were $0.50 million compared to $0.68 million for the same period in 2024, a decrease of 26.7%. The decrease in Energy Production revenue is due to contract expirations at certain energy production sites.

Gross Profit

  • Gross profit for the quarter ended March 31, 2025 was $3.22 million compared to $2.58 million in the same period in 2024. Gross margin increased to 44.3% in the quarter ended March 31, 2025 compared to 41.6% for the same period in 2024. The increase in gross margin was driven by improved Products and Energy Production margins in the quarter ended March 31, 2025.

Operating Expenses

  • Operating expenses increased $0.19 million, or 5.2%, to $3.82 million in the quarter ended March 31, 2025 compared to $3.63 million in the same period in 2024, due to increased payroll, benefits and recruitment costs.

Adjusted EBITDA

Adjusted EBITDAwas negative $0.38 million for the quarter ended March 31, 2025 compared to negative $0.90 million for the quarter ended March 31, 2024. (Adjusted EBITDA is defined as net income or loss attributable to Tecogen, adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges or gains including abandonment of intangible assets and asset impairment. See the table following the Condensed Consolidated Statements of Operations for a reconciliation from net income (loss) to Adjusted EBITDA, as well as important disclosures about the Company's use of Adjusted EBITDA).

Conference Call Scheduled for May 13, 2025, at 9:30 am ET

Tecogen will host a conference call on May 13, 2025 to discuss the first quarter results beginning at 9:30 am eastern time. To listen to the call please dial (877) 407-7186 within the U.S. and Canada, or +1 (201) 689-8052 from other international locations . Participants should ask to be joined to the Tecogen First Quarter conference call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us." The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days.

The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada , or (201) 612-7415 from other international locations and use Conference Call ID#: 13752231.

About Tecogen

Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit www.tecogen.com or contact us for a free Site Assessment .

Forward Looking Statements

This press release contains "forward-looking statements" which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements except as required under the securities laws.

In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and in our Current reports on Form 8-K, under "Risk Factors," and elsewhere therein, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, the impact of tariffs, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.

In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.

Tecogen Media & Investor Relations Contact Information:
Abinand Rangesh
P: 781-466-6487
E: Abinand.Rangesh@tecogen.com

TECOGEN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)

March 31, 2025

December 31, 2024

ASSETS
Cash and cash equivalents

$

4,066,793

$

5,405,233

Accounts receivable, net

5,849,511

6,026,545

Inventories, net

9,886,750

9,634,005

Unbilled revenue

126,738

398,898

Prepaid and other current assets

684,548

680,565

Total current assets

20,614,340

22,145,246

Long-term assets:
Property, plant and equipment, net

1,774,288

1,738,036

Right-of-use assets - operating leases

1,768,309

1,730,358

Right-of-use assets - finance leases

646,874

452,390

Intangible assets, net

2,421,355

2,513,189

Goodwill

2,346,566

2,346,566

Other assets

154,096

166,474

TOTAL ASSETS

$

29,725,828

$

31,092,259

Related party notes, current portion

$

512,187

$

1,548,872

Accounts payable

4,346,918

4,142,678

Accrued expenses

2,827,144

2,890,886

Deferred revenue, current portion

5,656,983

6,701,131

Operating lease obligations, current portion

456,370

430,382

Finance lease obligations, current portion

113,249

85,646

Acquisition liabilities, current portion

936,564

902,552

Unfavorable contract liability, current portion

97,376

113,449

Total current liabilities

14,946,791

16,815,596

Long-term liabilities:
Related party notes, net of current portion

1,055,122

-

Deferred revenue, net of current portion

1,169,075

1,165,951

Operating lease obligations, net of current portion

1,355,685

1,341,789

Finance lease obligations, net of current portion

457,865

325,235

Acquisition liabilities, net of current portion

938,407

1,008,760

Unfavorable contract liability, net of current portion

291,390

309,390

Total liabilities

20,214,335

20,966,721

Commitments and contingencies
Stockholders' equity:
Tecogen Inc. shareholders' equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 24,985,261 issued and outstanding at March 31, 2025 and 24,950,261 shares issued and outstanding at December 31, 2024

24,985

24,950

Additional paid-in capital

57,924,587

57,845,289

Accumulated deficit

(48,299,816

)

(47,639,894

)

Total Tecogen Inc. stockholders' equity

9,649,756

10,230,345

Non-controlling interest

(138,263

)

(104,807

)

Total stockholders' equity

9,511,493

10,125,538

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

29,725,828

$

31,092,259

TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

Three Months Ended

March 31, 2025

March 31, 2024

Revenues
Products

$

2,533,809

$

1,491,398

Services

4,245,022

4,014,310

Energy production

498,939

680,389

Total revenues

7,277,770

6,186,097

Cost of sales
Products

1,487,750

1,049,543

Services

2,258,898

2,092,257

Energy production

310,082

468,640

Total cost of sales

4,056,730

3,610,440

Gross profit

3,221,040

2,575,657

Operating expenses:
General and administrative

2,928,135

2,848,568

Selling

594,481

529,669

Research and development

292,668

254,696

Gain on disposition of assets

-

(7,391

)

Total operating expenses

3,815,284

3,625,542

Loss from operations

(594,244

)

(1,049,885

)

Other income (expense)
Other income (expense), net

(14,245

)

(15,747

)

Interest expense

(32,326

)

(18,670

)

Unrealized gain (loss) on investment securities

(18,749

)

18,749

Total other income (expense), net

(65,320

)

(15,668

)

Loss before provision for state income taxes

(659,564

)

(1,065,553

)

Provision for state income taxes

925

22,063

Consolidated net loss

(660,489

)

(1,087,616

)

(Income) loss attributable to the non-controlling interest

567

(17,351

)

Loss attributable to Tecogen Inc.

$

(659,922

)

$

(1,104,967

)

Net loss per share - basic

$

(0.03

)

$

(0.04

)

Weighted average shares outstanding - basic

24,954,928

24,850,261

Net loss per share - diluted

$

(0.03

)

$

(0.04

)

Weighted average shares outstanding - diluted

24,954,928

24,850,261

Three Months Ended

March 31, 2025

March 31, 2024

Non-GAAP financial disclosure (1)
Net loss attributable to Tecogen Inc.

$

(659,922

)

$

(1,104,967

)

Interest expense, net

32,326

18,670

Income taxes

925

22,063

Depreciation & amortization, net

185,695

140,137

EBITDA

(440,976

)

(924,097

)

Stock-based compensation

40,833

44,535

Unrealized gain on investment securities

18,749

(18,749

)

$

(381,394

)

$

(898,311

)

(1) Non-GAAP Financial Measures

In addition to reporting net income, a U.S. generally accepted accounting principle ("GAAP") measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets), which is a non-GAAP measure. The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. Adjusted EBITDA is not calculated through the application of GAAP. Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)



Three Months Ended



March 31, 2025

March 31, 2024

CASH FLOWS FROM OPERATING ACTIVITIES:





Consolidated net loss

$

(660,489

)

(1,087,616

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization

185,695

140,137

Provision for (recovery of) credit losses

(75,000

)

14,258

Stock-based compensation

40,833

44,535

Unrealized (loss) gain on investment securities

18,749

(18,749

)

Gain on disposition of assets

-

(7,391

)

Non-cash interest expense

18,852

6,400

Changes in operating assets and liabilities
(Increase) decrease in:
Accounts receivable

252,034

234,095

Inventory

(252,745

)

532,418

Unbilled revenue

272,160

-

Prepaid assets and other current assets

(3,983

)

(48,933

)

Other assets

71,264

194,283

Increase (decrease) in:
Accounts payable

204,237

(500,516

)

Accrued expenses and other current liabilities

(63,742

)

167,789

Deferred revenue

(1,041,023

)

791,181

Other liabilities

(140,245

)

(213,675

)

Net cash provided by (used in) operating activities

(1,173,403

)

248,216

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment

(132,020

)

(104,952

)

Proceeds from disposition of assets

-

33,013

Distributions to non-controlling interest

(32,889

)

-

Net cash used in investing activities

(164,909

)

(71,939

)

CASH FLOWS FROM FINANCING ACTIVITIES:
Finance lease principal payments

(38,628

)

(17,112

)

Proceeds from exercise of stock options

38,500

-

Net cash used in financing activities

(128

)

(17,112

)

Net increase (decrease) in cash and cash equivalents

(1,338,440

)

159,165

Cash and cash equivalents, beginning of the period

5,405,233

1,351,270

Cash and cash equivalents, end of the period

$

4,066,793

$

1,510,435

Supplemental disclosure of cash flow information:
Supplemental disclosure of cash flow information:
Cash paid for interest

$

13,474

$

11,855

Cash paid for taxes

$

925

$

425

Non-cash investing activities
Right-of-use assets acquired under operating leases

$

115,857

$

1,429,977

Right-of-use assets acquired under finance leases

$

226,794

$

200,187

Aegis Contract and Related Asset Acquisition:
Contingent consideration

$

-

$

92,409

SOURCE: Tecogen, Inc.



View the original press release on ACCESS Newswire

FAQ

What were Tecogen's (TGEN) Q1 2025 earnings results?

Tecogen reported Q1 2025 revenues of $7.28 million and a net loss of $0.66 million ($0.03 per share), compared to revenues of $6.19 million and a net loss of $1.10 million ($0.04 per share) in Q1 2024.

How much did Tecogen's (TGEN) revenue grow in Q1 2025?

Tecogen's revenue grew 17.6% year-over-year, from $6.19 million in Q1 2024 to $7.28 million in Q1 2025.

What was Tecogen's (TGEN) gross margin in Q1 2025?

Tecogen's gross margin increased to 44.3% in Q1 2025 from 41.6% in Q1 2024.

Why did Tecogen's operating expenses increase in Q1 2025?

Operating expenses increased 5.2% to $3.82 million due to increased payroll, benefits, recruitment costs, R&D expenses, and professional fees related to the NYSE American uplist.

What was the performance of Tecogen's different business segments in Q1 2025?

Products revenue increased 69.9% to $2.53 million, Services revenue grew 5.7% to $4.25 million, while Energy Production revenue decreased 26.7% to $0.50 million.
Tecogen

NYSE:TGEN

TGEN Rankings

TGEN Latest News

TGEN Stock Data

81.11M
13.17M
47.24%
0.04%
Electrical Equipment & Parts
Air-cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip
Link
United States
WALTHAM